StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
693
This month
6
This week
1
This year
39
Publishing Date
2023 - 12 - 08
4
2023 - 10 - 15
3
2023 - 06 - 12
3
2023 - 05 - 25
3
2023 - 05 - 02
3
2023 - 04 - 04
3
2023 - 01 - 30
3
2023 - 01 - 25
3
2022 - 12 - 22
3
2022 - 12 - 09
3
2022 - 12 - 01
3
2022 - 11 - 08
3
2022 - 11 - 02
3
2022 - 09 - 28
3
2022 - 08 - 25
3
2022 - 08 - 22
3
2022 - 08 - 18
3
2022 - 08 - 08
3
2022 - 07 - 28
3
2022 - 07 - 20
3
2022 - 06 - 27
3
2022 - 06 - 06
3
2022 - 05 - 24
3
2022 - 04 - 26
3
2022 - 03 - 29
4
2022 - 03 - 01
3
2022 - 01 - 05
3
2021 - 11 - 17
4
2021 - 11 - 09
5
2021 - 11 - 02
3
2021 - 10 - 21
3
2021 - 10 - 20
3
2021 - 09 - 28
6
2021 - 08 - 13
3
2021 - 08 - 12
3
2021 - 08 - 05
4
2021 - 07 - 23
4
2021 - 07 - 19
3
2021 - 06 - 24
4
2021 - 06 - 21
3
2021 - 06 - 16
3
2021 - 06 - 09
3
2021 - 05 - 20
4
2021 - 05 - 04
3
2021 - 04 - 28
3
2021 - 04 - 22
3
2021 - 03 - 25
2
2021 - 03 - 23
2
2021 - 03 - 19
4
2021 - 03 - 18
3
2021 - 03 - 11
2
2021 - 03 - 10
2
2021 - 03 - 08
2
2021 - 02 - 17
3
2021 - 01 - 12
2
2021 - 01 - 08
2
2020 - 12 - 28
2
2020 - 12 - 23
3
2020 - 12 - 21
2
2020 - 12 - 11
2
Sector
Commercial services
3
Communications
30
Consumer durables
3
Consumer non-durables
7
Consumer services
1
Distribution services
2
Electronic technology
6
Finance
11
Health services
3
Health technology
693
Industrial services
2
Manufacturing
44
N/a
14
Process industries
7
Producer manufacturing
3
Professional, scientific, and technical services
11
Retail trade
2
Technology services
4
Tags
Acquisition
9
Active
10
Antiviral
10
Application
24
Approval
31
Authorization
14
Breast
12
Cancer
66
Candidate
16
Children
18
Clinical-trials-phase-ii
9
Clinical-trials-phase-iii
15
Collaboration
21
Comirnaty®
10
Conference
18
Covid
58
Covid-19
41
Disease
28
Drug
54
Earnings
20
Ema
10
Emergency use authorization
10
Europe
13
Events
12
Expected
10
Fda
74
Fda-approvals
14
Financial
19
Global
56
Growth
29
Hiv
15
Hormone
10
License
19
Market
100
Merge
15
N/a
432
Order
15
People
24
Pharm-country
34
Pharmaceutical
17
Phase 2
12
Phase 3
21
Positive
45
Potential
11
Product-news
10
Regulatory
12
Report
49
Research
51
Respiratory
10
Results
62
Risk
16
Study
20
Therapeutics
40
Therapy
29
Topline
14
Treatment
74
Trial
47
Ulcerative colitis
12
Update
14
Vaccine
106
Entities
3m company
938
Abb ltd
1433
Abbott laboratories
1796
Abbvie inc.
1029
Accenture plc
602
Alphabet inc.
1303
Amgen inc.
744
Apple inc.
1198
Arcelormittal
592
Arrival
4311
Astrazeneca plc
667
Bank of montreal
545
Becton, dickinson and company
796
Bnp paribas
1768
Boston scientific corporation
576
Bristol-myers squibb company
662
Broadcom inc.
597
Cisco systems, inc.
900
Cummins inc.
542
Danaher corporation
786
Dell technologies inc.
579
Dow inc.
556
Eli lilly and company
1711
Ericsson
1614
Extreme networks, inc.
581
First bank
600
Ford motor company
643
Gartner, inc.
595
General electric company
918
Glaxosmithkline plc
888
Honeywell international inc.
1791
Hubspot, inc.
1400
Intel corporation
955
International business machines corporation
655
Johnson & johnson
4599
Kering
1132
Koninklijke philips n.v.
963
Lithium corp
972
Live nation entertainment, inc.
717
Lockheed martin corporation
576
Medtronic plc
1286
Microsoft corporation
1203
Morgan stanley
4291
Nokia corp
980
Nokia corporation
904
Northrop grumman corporation
589
Novartis ag
1245
Novo nordisk a/s
634
Oracle corporation
1160
Orange
7220
Panasonic corp
651
Pfizer, inc.
693
Sanofi
4552
Sap se
1480
Snowflake inc.
796
Stryker corporation
536
Teva pharmaceutical industries ltd
633
Thermo fisher scientific inc
1628
Verizon communications inc.
1221
X financial
678
Symbols
ABBV
37
ABT
32
ADCT
5
AERI
5
AGIO
10
ALKS
4
ALNY
14
ALPMF
26
ALPMY
26
AMGN
34
ARVN
24
AVEO
10
AZN
45
AZNCF
35
BAX
6
BCRX
14
BDX
6
BEAM
6
BGNE
10
BHC
5
BHVN
15
BMY
61
BNTX
95
BPMC
10
CLVS
11
ENDP
7
EPZM
11
EXEL
13
FNCTF
29
GBT
6
GILD
27
GLAXF
42
GSK
64
ILMN
12
INCY
14
IONS
5
JNJ
76
KPTI
10
LLY
80
MRNA
7
MYOV
14
NVO
11
NVS
88
NVSEF
68
OMER
13
OPK
6
OTIC
13
PFE
693
REGN
22
RIGL
11
SGEN
7
SNY
153
SNYNF
90
TAK
23
TEVJF
29
VSTM
10
VTRS
8
VYGR
6
XERS
10
YMAB
10
Exchanges
Amex
5
Nasdaq
423
Nyse
693
Crawled Date
2024 - 02 - 27
3
2023 - 12 - 08
4
2023 - 10 - 16
5
2023 - 06 - 12
3
2023 - 05 - 25
3
2023 - 05 - 02
3
2023 - 04 - 04
3
2023 - 01 - 25
3
2022 - 12 - 22
3
2022 - 12 - 01
3
2022 - 11 - 08
3
2022 - 09 - 28
3
2022 - 08 - 25
3
2022 - 08 - 22
3
2022 - 08 - 18
3
2022 - 08 - 08
3
2022 - 07 - 28
3
2022 - 07 - 20
3
2022 - 06 - 27
3
2022 - 06 - 06
3
2022 - 05 - 24
3
2022 - 04 - 26
3
2022 - 03 - 29
3
2022 - 03 - 01
3
2022 - 01 - 05
3
2021 - 11 - 17
4
2021 - 11 - 09
5
2021 - 11 - 02
3
2021 - 10 - 21
3
2021 - 10 - 20
3
2021 - 09 - 28
6
2021 - 08 - 13
3
2021 - 08 - 12
3
2021 - 08 - 05
4
2021 - 07 - 23
3
2021 - 07 - 19
3
2021 - 06 - 24
4
2021 - 06 - 16
3
2021 - 06 - 09
3
2021 - 05 - 20
4
2021 - 05 - 04
3
2021 - 04 - 28
3
2021 - 04 - 22
3
2021 - 04 - 13
3
2021 - 04 - 01
2
2021 - 03 - 31
2
2021 - 03 - 26
2
2021 - 03 - 25
2
2021 - 03 - 23
2
2021 - 03 - 19
4
2021 - 03 - 18
3
2021 - 03 - 11
2
2021 - 03 - 10
2
2021 - 03 - 08
2
2021 - 02 - 17
3
2021 - 01 - 12
2
2020 - 12 - 28
2
2020 - 12 - 23
3
2020 - 12 - 21
2
2020 - 12 - 11
3
Crawled Time
00:00
25
00:01
1
00:20
4
01:00
15
02:00
6
03:00
1
04:00
4
04:20
1
05:00
9
05:03
1
05:10
1
06:00
8
06:03
2
07:00
10
08:00
3
08:20
3
09:00
11
09:01
1
10:00
16
10:51
1
11:00
66
11:01
1
12:00
90
12:03
1
12:15
4
12:20
16
12:30
12
12:34
1
13:00
45
13:01
1
13:07
1
13:14
1
13:15
3
13:17
1
13:20
6
13:27
1
13:30
6
13:50
1
13:55
1
14:00
39
14:03
1
14:15
2
14:20
5
14:30
1
15:00
34
15:15
3
15:20
9
15:21
1
15:28
1
15:30
4
16:00
39
16:20
2
17:00
27
18:00
23
18:31
2
19:00
20
20:00
17
21:00
27
22:00
26
23:00
14
Source
ir.akerotx.com
2
ir.vaccinex.com
1
ir.voyagertherapeutics.com
3
mindmed.co
1
www.4dpharmaplc.com
1
www.achievelifesciences.com
2
www.biospace.com
261
www.chi-med.com
1
www.eyenoviabio.com
1
www.fda.gov
31
www.globenewswire.com
147
www.prnewswire.com
242
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Pfizer, inc.
save search
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
Published:
2024-04-22
(Crawled : 14:00)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
1.23%
|
O:
0.0%
H:
1.92%
C:
1.0%
emblaveo
treatment
for
infections
Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25
Published:
2024-04-11
(Crawled : 20:00)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
0.0%
|
O:
0.11%
H:
0.38%
C:
-0.04%
meeting
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
Published:
2024-04-09
(Crawled : 12:00)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-0.88%
|
O:
0.73%
H:
2.49%
C:
0.11%
abrysvo
disease
positive
risk
for
rsv
results
study
NIIMBL Announces $10M for 8 New Biopharmaceutical Manufacturing Projects
Published:
2024-04-09
(Crawled : 18:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-1.72%
|
O:
-0.97%
H:
0.26%
C:
-0.75%
for
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
Published:
2024-04-08
(Crawled : 13:30)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-1.28%
|
O:
-0.39%
H:
0.0%
C:
0.0%
fda
approval
for
hiv
living
ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager
Published:
2024-04-08
(Crawled : 17:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-1.28%
|
O:
-0.39%
H:
0.0%
C:
0.0%
DOW
|
$56.74
-0.44%
0.0%
3.1M
|
Process Industries
|
-4.94%
|
O:
0.44%
H:
0.4%
C:
-0.72%
dean
Bluerock Value Exchange Fully Subscribes $46.5 Million Diversified Industrial Portfolio I DST
Published:
2024-03-27
(Crawled : 13:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-4.6%
|
O:
0.43%
H:
0.81%
C:
0.25%
million
Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
Published:
2024-03-26
(Crawled : 21:00)
- globenewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-4.6%
|
O:
0.43%
H:
0.81%
C:
0.25%
therapeutics
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
Published:
2024-03-19
(Crawled : 11:00)
- globenewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-5.05%
|
O:
-0.18%
H:
0.4%
C:
-0.14%
pharmaceuticals
Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
Published:
2024-03-18
(Crawled : 21:00)
- globenewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-5.05%
|
O:
-0.18%
H:
0.4%
C:
-0.14%
ARVN
|
$33.96
-2.69%
-2.77%
530K
|
Health Technology
|
-20.19%
|
O:
-3.22%
H:
4.58%
C:
3.23%
medical
European Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
Published:
2024-03-13
(Crawled : 11:00)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-6.03%
|
O:
1.0%
H:
1.41%
C:
-0.25%
disease
pneumococcal
children
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
Published:
2024-03-12
(Crawled : 12:00)
- globenewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-7.23%
|
O:
-0.21%
H:
0.11%
C:
-1.06%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
0.64%
|
O:
0.9%
H:
2.03%
C:
1.89%
VERU
|
$1.27
0.0%
2.6M
|
Health Technology
|
93.01%
|
O:
-0.53%
H:
2.22%
C:
-3.59%
ALT
|
$7.56
1.21%
1.19%
3.1M
|
Commercial Services
|
-23.3%
|
O:
0.3%
H:
11.41%
C:
9.8%
medical
program
Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Published:
2024-03-12
(Crawled : 12:30)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-7.23%
|
O:
-0.21%
H:
0.11%
C:
-1.06%
adcetris
positive
trial
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published:
2024-03-07
(Crawled : 12:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-3.2%
|
O:
0.04%
H:
0.44%
C:
-1.51%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-3.68%
|
O:
-2.08%
H:
0.13%
C:
-0.57%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-8.22%
|
O:
0.36%
H:
0.34%
C:
-0.54%
XFOR
|
$1.225
-9.93%
-11.02%
3.5M
|
Health Technology
|
27.66%
|
O:
0.12%
H:
0.0%
C:
-4.98%
EYPT
|
News
|
$17.565
3.63%
3.5%
940K
|
Health Technology
|
-31.74%
|
O:
2.56%
H:
1.37%
C:
-4.13%
AQST
|
$4.265
-2.63%
-2.7%
1.7M
|
Health Technology
|
-14.91%
|
O:
1.79%
H:
12.3%
C:
10.94%
ALKS
|
$24.26
0.79%
0.78%
1.2M
|
Health Technology
|
-16.17%
|
O:
1.11%
H:
0.96%
C:
0.65%
Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024
Published:
2024-03-06
(Crawled : 01:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
0.92%
|
O:
3.14%
H:
1.49%
C:
1.08%
KZR
|
$0.8232
0.15%
0.15%
520K
|
Health Technology
|
-19.42%
|
O:
1.94%
H:
0.0%
C:
-1.9%
financial
results
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference - March 5, 2024
Published:
2024-03-05
(Crawled : 16:00)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
1.66%
|
O:
-0.08%
H:
2.13%
C:
0.81%
conference
ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses
Published:
2024-03-04
(Crawled : 21:00)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-1.02%
|
O:
-1.09%
H:
0.61%
C:
-1.56%
trial
Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
Published:
2024-02-29
(Crawled : 16:00)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-2.66%
|
O:
0.11%
H:
0.44%
C:
-1.88%
abrysvo
positive
rsv
Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published:
2024-02-27
(Crawled : 12:00)
- globenewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-3.16%
|
O:
-0.22%
H:
0.29%
C:
-0.85%
ARVN
|
$33.96
-2.69%
-2.77%
530K
|
Health Technology
|
-30.31%
|
O:
0.0%
H:
1.25%
C:
-1.6%
year
update
financial
results
Kalderos Attracts Two Recognized Industry Leaders to Board of Directors
Published:
2024-02-27
(Crawled : 14:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-3.16%
|
O:
-0.22%
H:
0.29%
C:
-0.85%
leaders
← Previous
1
2
3
4
5
6
7
8
9
…
34
35
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.